Less Ads, More Data, More Tools Register for FREE

Pin to quick picksReal Est.cred Regulatory News (RECI)

Share Price Information for Real Est.cred (RECI)

Share Price is delayed by 15 minutes
Get Live Data
116.50    1.00 (0.87%)
Bid:
116.50
Ask:
117.50
Spread: 1.00 (0.858%)
Market Cap: £257.52m
RECI Live PriceLast checked at - London Stock Exchange

Intraday Real Est.cred Share Chart

Further Buyback Programme

27 Sep 2024 07:00

RNS Number : 8848F
Real Estate Credit Investments Ltd
27 September 2024
 

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, TO ANY US PERSONS OR INTO, THE UNITED STATES, AUSTRALIA, CANADA, SOUTH AFRICA OR JAPAN, OR ANY OTHER JURISDICTION, OR TO ANY PERSON, WHERE DOING SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION.

This announcement contains inside information as defined under the Market Abuse Regulation. (EU) No. 596/2014 as it forms part of UK Domestic Law by virtue of the European Union (Withdrawal) Act 2018. This announcement has been prepared by, and is the sole responsibility of, Real Estate Credit Investments Limited. This announcement has been released by Lucy McDowall of Aztec Financial Services (Guernsey) Limited, Secretary of the Company.

 27 September 2024

Real Estate Credit Investments Limited

("RECI" or the "Company")

Further Buyback Programme

The Board of Directors of Real Estate Credit Investments Limited announces that, having reviewed the current circumstances and assessed the Company's level and allocation of cash available for deployment, it intends to undertake a further buyback programme (the "Programme") which will run to 31 March 2025. The aggregate purchase price of all shares acquired under the Programme will be no greater than £10.0 million. The Company's buyback programme announced on 28 March 2024 will expire on 30 September 2024.

 

The Company's initial buyback programme was announced on 31 August 2023, with an aggregate purchase price of all shares purchased of no more than £5.0 million. Pursuant to that programme, a total of 4,095,000 ordinary shares of no par value each ("Ordinary Shares") were purchased for treasury for an aggregate amount of £5.0 million. Ordinary Shares were repurchased under the initial programme at an average discount to net asset value per share of 16.2%, with the Company's Ordinary Shares trading at an average discount of 14.1% from 31 August 2023 to 25 March 2024 (the date of the last share repurchase under the programme). The Company's successor buyback programme was announced on 28 March 2024, with an aggregate purchase price of all shares purchased of no more than £10.0 million. Pursuant to that programme, a total of 3,343,474 Ordinary Shares were purchased for treasury for an aggregate amount of £4,148,809. Ordinary Shares were repurchased under that programme at an average discount to net asset value per share of 15.5%, with the Company's Ordinary Shares trading at an average discount of 17.0% from 1 April 2024 to 25 September 2024 (the latest practicable date).

 

As announced in its recent annual report, the Company considers all options when deciding on the appropriate allocation of the Company's available cash resources, including implementing share buybacks such as the current and future up to £10 million programmes and investment in attractive high yielding opportunities to enhance RECI's returns, such as the new investment announced on 16 July 2024. In the period from the announcement of the current buyback programme to 25 September 2024 the Company's NAV increased from 144.5p (as at 31 March 2024) to 147.5p (31 August 2024) and the share price increased from 114.5p to 130.0p. This has resulted in a significant reduction in the share price discount to 11.9% from 21.9% at the outset. As a result of these factors and reflecting third party investor appetite to acquire the Company's shares, Panmure Liberum Limited ("Panmure Liberum") on behalf of the Company has not deployed the full amount of capital available under the programme. Nevertheless, the Company remains committed to considering the ongoing deployment of available cash resources to share buybacks as confirmed by the introduction of this successor programme of up to £10 million for a further six months.

 

The Programme will occur within the limitations of RECI's existing general authority to purchase no more than 33,491,382 Ordinary Shares as granted by shareholders at the Company's annual general meeting held on 18 September 2024.

The Company has appointed Panmure Liberum to make market purchases of Ordinary Shares in respect of the Programme. Panmure Liberum will purchase the Ordinary Shares as principal (and not as agent) and sell them on to the Company. The Company intends that any Ordinary Shares purchased by the Company will be held in treasury. 

Any share purchases will be made in accordance with certain pre-set parameters set out in the terms of Panmure Liberum's engagement, the general authority of the Company to repurchase shares granted by shareholders at the Company's 2024 annual general meeting; and the EU Market Abuse Regulation (596/2014) as it forms part of domestic law by virtue of section 3 of the European Union (Withdrawal) Act 2018 (as amended); and Chapter 9 of the Financial Conduct Authority's UK Listing Rules.

The maximum price payable per share (exclusive of expenses) must not exceed the higher of: (i) 105% of the average middle market quotations for the five business days preceding the date of purchase; and (ii) the higher of the last independent trade and the highest current independent bid on the London Stock Exchange.

A buy-back of Ordinary Shares on any trading day may represent a significant proportion of the daily trading volume in the Ordinary Shares on the Exchange (and could exceed the 25% limit of the average daily trading volume of the preceding 20 business days as referred to in the Commission Delegated Regulation (EU) No. 2016/1052 on buy-back programmes (as it forms part of UK law by virtue of the European Union (Withdrawal) Act 2018)).

Any purchase of Ordinary Shares by the Company will be notified through an RIS announcement by no later than 7.30 a.m. on the following business day. Shareholders should note that whether a buyback of Ordinary Shares is made is based on a number of factors and, accordingly, no expectation or reliance should be placed on Panmure Liberum exercising such discretion on any one or more occasions. There is no guarantee that the Programme will be implemented in full or that any Ordinary Shares will be repurchased by the Company.

 

Enquiries:

Cheyne Capital Management (UK) LLP (Investment Manager)

+44 (0) 20 7968 7450

RECIIR@cheynecapital.com

 

 

Panmure Liberum (Corporate Broker)

+44 (0) 20 3100 2222

Darren Vickers/Alex Collins

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCQQLFLZKLZBBQ
Date   Source Headline
18th May 20267:00 amRNSFact Sheet Announcement
29th Apr 20267:00 amRNSFact Sheet Announcement
31st Mar 20267:00 amRNSUpdate on Buyback Programme
20th Mar 20263:51 pmRNSDirector/PDMR Shareholding
17th Mar 20267:00 amRNSFact Sheet Announcement
17th Mar 20267:00 amRNSFact Sheet Announcement
12th Mar 20267:00 amRNSTransaction in Own Shares
11th Mar 20267:00 amRNSTransaction in Own Shares
11th Mar 20267:00 amRNSTransaction in Own Shares
10th Mar 20265:41 pmRNSDirector/PDMR Shareholding
10th Mar 20267:00 amRNSTransaction in Own Shares
26th Feb 202612:30 pmRNSDividend Declaration Update
18th Feb 20263:51 pmRNSDividend Declaration
16th Feb 20267:00 amRNSFact Sheet Announcement
20th Jan 20267:00 amRNSFact Sheet Announcement
14th Jan 20269:30 amRNSDirectorsTalk Interview
19th Dec 20257:00 amRNSFact Sheet Announcement
19th Dec 20257:00 amRNSFact Sheet Announcement
10th Dec 202510:37 amRNSDirector/PDMR Shareholding
4th Dec 20255:47 pmRNSDirectorsTalk Interview
4th Dec 202512:59 pmRNSDirector/PDMR Shareholding
27th Nov 20257:01 amRNSDividend Declaration
27th Nov 20257:00 amRNSHalf-year Financial Report
20th Nov 20257:00 amRNSFact Sheet Announcement
27th Oct 20257:00 amRNSShare Buyback Programme in a Closed Period
24th Oct 20257:00 amRNSFact Sheet Announcement
30th Sep 20257:00 amRNSExtension of Buyback Programme
17th Sep 20253:45 pmRNSDividend Declaration
17th Sep 20253:13 pmRNSResult of AGM
12th Sep 20257:00 amRNSFact Sheet Announcement
4th Sep 20253:58 pmRNSPostponement of RECI Investor Day
26th Aug 20253:34 pmRNSDirector/PDMR Shareholding
19th Aug 20257:00 amRNSFact Sheet Announcement
12th Aug 20257:00 amRNSNotice of AGM
28th Jul 20257:00 amRNSRECI Investor Day - 8 September 2025
15th Jul 20257:00 amRNSFact Sheet Announcement
25th Jun 20257:00 amRNSDividend Declaration
25th Jun 20257:00 amRNSAnnual Financial Report
11th Jun 20257:00 amRNSFact Sheet Announcement
21st May 20255:18 pmRNSDirector Declaration - Additional Directorship
19th May 20257:00 amRNSFact Sheet Announcement
17th Apr 20257:00 amRNSFact Sheet Announcement
8th Apr 20257:00 amRNSTransaction in Own Shares
31st Mar 20253:30 pmRNSFurther Buyback Programme
20th Mar 20251:32 pmRNSDirector/PDMR Shareholding
17th Mar 20257:00 amRNSFact Sheet Announcement
14th Mar 20254:34 pmRNSDirector/PDMR Shareholding
19th Feb 20252:59 pmRNSDividend Declaration
14th Feb 20257:00 amRNSFact Sheet Announcement
22nd Jan 20257:00 amRNSFact Sheet Announcement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.